Balyasny Asset Management »

Cerevel Therapeutics Hldng I shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $24M 596k 40.89
2024-03-31 $46M 1.1M 42.27
2023-12-31 $95M 2.2M 42.40
2023-09-30 $650k 30k 21.83
2023-06-30 $3.5M 111k 31.79
2023-03-31 $8.5M 350k 24.39

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Vanguard Group
BlackRock
State Street Corporation
Alliancebernstein
Qube Research & Technologies
Farallon Capital Management
Melqart Asset Management
Goldman Sachs Group
P. Schoenfeld Asset Management
Water Island Capital
Squarepoint Ops
Balyasny Asset Management
Hsbc Holdings
Morgan Stanley

View all funds holding Cerevel Therapeutics Hldng I